{
    "startDate": "2021-01-01",
    "endDate": "2021-06-30",
    "year": "2021",
    "quarter": "Q2",
    "symbol": "BBIO",
    "data": {
        "bs": [
            {
                "label": "Total liabilities, redeemable convertible noncontrolling interests and stockholders\u2019 equity (deficit)",
                "concept": "LiabilitiesAndStockholdersEquity",
                "unit": "usd",
                "value": 1081486000
            },
            {
                "label": "Receivable from licensing and collaboration agreements",
                "concept": "bbio:ReceivableCurrentFromLicensingAndCollaborationAgreements",
                "unit": "usd",
                "value": 35363000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "PrepaidExpenseAndOtherAssetsCurrent",
                "unit": "usd",
                "value": 26670000
            },
            {
                "label": "Term loans, net of current portion",
                "concept": "LongTermDebtNoncurrent",
                "unit": "usd",
                "value": 102611000
            },
            {
                "label": "Commitments and contingencies (Note 8)",
                "concept": "CommitmentsAndContingencies",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Other assets",
                "concept": "OtherAssetsNoncurrent",
                "unit": "usd",
                "value": 49797000
            },
            {
                "label": "Other accrued liabilities",
                "concept": "OtherAccruedLiabilitiesCurrent",
                "unit": "usd",
                "value": 21177000
            },
            {
                "label": "Accumulated deficit",
                "concept": "RetainedEarningsAccumulatedDeficit",
                "unit": "usd",
                "value": -1133854000
            },
            {
                "label": "Property and equipment, net",
                "concept": "PropertyPlantAndEquipmentNet",
                "unit": "usd",
                "value": 26272000
            },
            {
                "label": "Long-term marketable securities",
                "concept": "MarketableSecuritiesNoncurrent",
                "unit": "usd",
                "value": 60688000
            },
            {
                "label": "Total BridgeBio stockholders\u2019 equity (deficit)",
                "concept": "StockholdersEquity",
                "unit": "usd",
                "value": -464294000
            },
            {
                "label": "Accrued research and development liabilities",
                "concept": "bbio:AccruedResearchAndDevelopmentLiabilitiesCurrent",
                "unit": "usd",
                "value": 55620000
            },
            {
                "label": "Noncontrolling interests",
                "concept": "MinorityInterest",
                "unit": "usd",
                "value": 6804000
            },
            {
                "label": "Common stock, $0.001 par value; 500,000,000 shares authorized; 152,894,108 shares issued and 149,614,740 shares outstanding as of June 30, 2021, 125,264,070 shares issued and 122,849,389 shares outstanding as of December 31, 2020",
                "concept": "CommonStockValue",
                "unit": "usd",
                "value": 153000
            },
            {
                "label": "Investment in equity securities",
                "concept": "bbio:InvestmentsInEquitySecurities",
                "unit": "usd",
                "value": 18894000
            },
            {
                "label": "Total assets",
                "concept": "Assets",
                "unit": "usd",
                "value": 1081486000
            },
            {
                "label": "Redeemable convertible noncontrolling interests",
                "concept": "TemporaryEquityCarryingAmountIncludingPortionAttributableToNoncontrollingInterests",
                "unit": "usd",
                "value": 1865000
            },
            {
                "label": "Accrued professional services",
                "concept": "AccruedProfessionalFeesCurrent",
                "unit": "usd",
                "value": 6378000
            },
            {
                "label": "Accrued compensation and benefits",
                "concept": "EmployeeRelatedLiabilitiesCurrent",
                "unit": "usd",
                "value": 21865000
            },
            {
                "label": "Accumulated other comprehensive income (loss)",
                "concept": "AccumulatedOtherComprehensiveIncomeLossNetOfTax",
                "unit": "usd",
                "value": 36000
            },
            {
                "label": "Accounts receivable",
                "concept": "AccountsReceivableNetCurrent",
                "unit": "usd",
                "value": 1213000
            },
            {
                "label": "Total stockholders\u2019 equity (deficit)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -457490000
            },
            {
                "label": "Total stockholders\u2019 equity (deficit)",
                "concept": "StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -457490000
            },
            {
                "label": "Accounts payable",
                "concept": "AccountsPayableCurrent",
                "unit": "usd",
                "value": 22329000
            },
            {
                "label": "Other liabilities",
                "concept": "OtherLiabilitiesNoncurrent",
                "unit": "usd",
                "value": 13265000
            },
            {
                "label": "Receivable from a related party",
                "concept": "DueFromRelatedPartiesCurrent",
                "unit": "usd",
                "value": 8962000
            },
            {
                "label": "Total current liabilities",
                "concept": "LiabilitiesCurrent",
                "unit": "usd",
                "value": 131909000
            },
            {
                "label": "Operating lease right-of-use assets, net",
                "concept": "OperatingLeaseRightOfUseAsset",
                "unit": "usd",
                "value": 15964000
            },
            {
                "label": "Short-term marketable securities",
                "concept": "MarketableSecuritiesCurrent",
                "unit": "usd",
                "value": 459243000
            },
            {
                "label": "Operating lease liabilities, current portion",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 4540000
            },
            {
                "label": "Operating lease liabilities, current portion",
                "concept": "OperatingLeaseLiabilityCurrent",
                "unit": "usd",
                "value": 4540000
            },
            {
                "label": "Treasury stock, at cost; 3,279,368 shares as of June 30, 2021, 2,414,681 shares as of December 31, 2020",
                "concept": "TreasuryStockValue",
                "unit": "usd",
                "value": 130308000
            },
            {
                "label": "Operating lease liabilities, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 18022000
            },
            {
                "label": "Operating lease liabilities, net of current portion",
                "concept": "OperatingLeaseLiabilityNoncurrent",
                "unit": "usd",
                "value": 18022000
            },
            {
                "label": "Undesignated preferred stock, $0.001 par value; 25,000,000 shares authorized; no shares issued and outstanding",
                "concept": "PreferredStockValue",
                "unit": "usd",
                "value": "N/A"
            },
            {
                "label": "Total current assets",
                "concept": "AssetsCurrent",
                "unit": "usd",
                "value": 909871000
            },
            {
                "label": "Additional paid-in capital",
                "concept": "AdditionalPaidInCapitalCommonStock",
                "unit": "usd",
                "value": 799679000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 378420000
            },
            {
                "label": "Cash and cash equivalents",
                "concept": "CashAndCashEquivalentsAtCarryingValue",
                "unit": "usd",
                "value": 378420000
            },
            {
                "label": "Total liabilities",
                "concept": "Liabilities",
                "unit": "usd",
                "value": 1537111000
            }
        ],
        "cf": [
            {
                "label": "Repayment of term loan",
                "concept": "RepaymentsOfLongTermDebt",
                "unit": "usd",
                "value": 18108000
            },
            {
                "label": "Recognized intangible asset recorded in Accrued research and development liabilities",
                "concept": "bbio:RecognizedIntangibleAssetRecordedInAccruedResearchAndDevelopmentLiabilities",
                "unit": "usd",
                "value": 20000000
            },
            {
                "label": "Investment in equity securities",
                "concept": "PaymentsToAcquireEquityMethodInvestments",
                "unit": "usd",
                "value": 20000000
            },
            {
                "label": "Repurchase of Eidos noncontrolling interest, including direct transaction costs",
                "concept": "bbio:RepurchaseOfNoncontrollingInterestIncludingDirectTransactionCosts",
                "unit": "usd",
                "value": 84840000
            },
            {
                "label": "Net noncash portion of repurchase of Eidos noncontrolling interests",
                "concept": "bbio:NetNonCashPortionOfRepurchaseOfNoncontrollingInterests",
                "unit": "usd",
                "value": 38167000
            },
            {
                "label": "Other assets",
                "concept": "IncreaseDecreaseInOtherOperatingAssets",
                "unit": "usd",
                "value": 5723000
            },
            {
                "label": "Increase in cash and cash equivalents from consolidation of PellePharm",
                "concept": "bbio:ProceedsFromConsolidationOfEntities",
                "unit": "usd",
                "value": 13654000
            },
            {
                "label": "Receivable from a related party",
                "concept": "IncreaseDecreaseInDueFromRelatedParties",
                "unit": "usd",
                "value": 8962000
            },
            {
                "label": "Maturities of marketable securities",
                "concept": "ProceedsFromSaleAndMaturityOfMarketableSecurities",
                "unit": "usd",
                "value": 238934000
            },
            {
                "label": "Proceeds from BridgeBio common stock issuances under ESPP",
                "concept": "ProceedsFromStockPlans",
                "unit": "usd",
                "value": 1652000
            },
            {
                "label": "Net cash provided by financing activities",
                "concept": "NetCashProvidedByUsedInFinancingActivities",
                "unit": "usd",
                "value": 546521000
            },
            {
                "label": "Accounts payable",
                "concept": "IncreaseDecreaseInAccountsPayable",
                "unit": "usd",
                "value": 13025000
            },
            {
                "label": "Net increase in cash, cash equivalents and restricted cash",
                "concept": "CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect",
                "unit": "usd",
                "value": 22449000
            },
            {
                "label": "Noncash contribution by an NCI",
                "concept": "bbio:NoncashOrPartNoncashContributionsMadeByNoncontrollingInterests",
                "unit": "usd",
                "value": 21600000
            },
            {
                "label": "Net cash used in operating activities",
                "concept": "NetCashProvidedByUsedInOperatingActivities",
                "unit": "usd",
                "value": -242478000
            },
            {
                "label": "Leasehold improvement paid by landlord",
                "concept": "PaymentsForTenantImprovements",
                "unit": "usd",
                "value": 2136000
            },
            {
                "label": "Transfers from noncontrolling interests (Note 6)",
                "concept": "bbio:NoncashOrPartNoncashInvestingTransferFromToNoncontrollingInterest",
                "unit": "usd",
                "value": 274000
            },
            {
                "label": "Proceeds from issuance of 2029 Notes in 2021 and 2027 Notes in 2020",
                "concept": "ProceedsFromConvertibleDebt",
                "unit": "usd",
                "value": 747500000
            },
            {
                "label": "Proceeds from stock option exercises, net of repurchases",
                "concept": "ProceedsFromStockOptionsExercised",
                "unit": "usd",
                "value": 11216000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -273156000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -273156000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -273156000
            },
            {
                "label": "Other noncash adjustments",
                "concept": "OtherNoncashIncomeExpense",
                "unit": "usd",
                "value": -7206000
            },
            {
                "label": "Issuance costs and discounts associated with issuance of 2029 Notes and 2027 Notes",
                "concept": "PaymentsOfDebtIssuanceCosts",
                "unit": "usd",
                "value": 16064000
            },
            {
                "label": "Repurchase of common stock",
                "concept": "PaymentsForRepurchaseOfCommonStock",
                "unit": "usd",
                "value": 55308000
            },
            {
                "label": "Accrued professional services",
                "concept": "bbio:IncreaseDecreaseInAccruedProfessionalService",
                "unit": "usd",
                "value": 1499000
            },
            {
                "label": "Accrued research and development liabilities",
                "concept": "bbio:IncreaseDecreaseInAccruedResearchAndDevelopmentLiabilities",
                "unit": "usd",
                "value": 2463000
            },
            {
                "label": "LEO call option expense (income)",
                "concept": "bbio:CallOptionExpenseIncome",
                "unit": "usd",
                "value": -5550000
            },
            {
                "label": "Cash paid for interest",
                "concept": "InterestPaidNet",
                "unit": "usd",
                "value": 10814000
            },
            {
                "label": "Net cash used in investing activities",
                "concept": "NetCashProvidedByUsedInInvestingActivities",
                "unit": "usd",
                "value": -281594000
            },
            {
                "label": "Direct transaction costs in the repurchase of Eidos recorded in Additional paid-in capital previously classified in prepaid expenses and other current assets",
                "concept": "bbio:DirectTransactionCostsInRepurchaseOfNoncontrollingInterestRecordedInAdditionalPaidInCapitalPreviouslyClassifiedInPrepaidExpensesAndOtherCurrentAssets",
                "unit": "usd",
                "value": 8749000
            },
            {
                "label": "Purchase of capped calls",
                "concept": "bbio:PurchaseOfCappedCalls",
                "unit": "usd",
                "value": 61295000
            },
            {
                "label": "Transactions with noncontrolling interests",
                "concept": "bbio:ProceedsFromIssuanceOfNoncontrollingInterest",
                "unit": "usd",
                "value": 70000
            },
            {
                "label": "Receivable from licensing and collaboration agreements",
                "concept": "bbio:IncreaseDecreaseReceivableFromLicensingAndCollaborationAgreements",
                "unit": "usd",
                "value": 35363000
            },
            {
                "label": "Prepaid expenses and other current assets",
                "concept": "IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets",
                "unit": "usd",
                "value": -1400000
            },
            {
                "label": "Repurchase of shares to satisfy tax withholding",
                "concept": "PaymentsRelatedToTaxWithholdingForShareBasedCompensation",
                "unit": "usd",
                "value": 3302000
            },
            {
                "label": "Accretion of debt",
                "concept": "AccretionExpense",
                "unit": "usd",
                "value": 2653000
            },
            {
                "label": "Proceeds from term loan",
                "concept": "ProceedsFromDebtNetOfIssuanceCosts",
                "unit": "usd",
                "value": 25000000
            },
            {
                "label": "Operating lease liabilities",
                "concept": "bbio:IncreaseDecreaseInOperatingLeaseLiabilities",
                "unit": "usd",
                "value": -2776000
            },
            {
                "label": "Stock-based compensation",
                "concept": "ShareBasedCompensation",
                "unit": "usd",
                "value": 63689000
            },
            {
                "label": "Purchases of property and equipment",
                "concept": "PaymentsToAcquirePropertyPlantAndEquipment",
                "unit": "usd",
                "value": 4248000
            },
            {
                "label": "Purchases of marketable securities",
                "concept": "PaymentsToAcquireMarketableSecurities",
                "unit": "usd",
                "value": 509934000
            },
            {
                "label": "Other accrued and other liabilities",
                "concept": "IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities",
                "unit": "usd",
                "value": 2599000
            },
            {
                "label": "Accounts receivable",
                "concept": "IncreaseDecreaseInAccountsReceivable",
                "unit": "usd",
                "value": 1040000
            },
            {
                "label": "Depreciation and amortization",
                "concept": "DepreciationDepletionAndAmortization",
                "unit": "usd",
                "value": 4052000
            },
            {
                "label": "Accrued compensation and benefits",
                "concept": "IncreaseDecreaseInEmployeeRelatedLiabilities",
                "unit": "usd",
                "value": -8494000
            }
        ],
        "ic": [
            {
                "label": "Net loss attributable to common stockholders of BridgeBio",
                "concept": "NetIncomeLossAvailableToCommonStockholdersBasic",
                "unit": "usd",
                "value": -259427000
            },
            {
                "label": "Total revenue",
                "concept": "RevenueFromContractWithCustomerExcludingAssessedTax",
                "unit": "usd",
                "value": 54486000
            },
            {
                "label": "Other income (expense), net",
                "concept": "OtherNonoperatingIncomeExpense",
                "unit": "usd",
                "value": 8223000
            },
            {
                "label": "Interest expense",
                "concept": "InterestExpense",
                "unit": "usd",
                "value": 20577000
            },
            {
                "label": "Total other income (expense), net",
                "concept": "NonoperatingIncomeExpense",
                "unit": "usd",
                "value": -11637000
            },
            {
                "label": "Research and development",
                "concept": "ResearchAndDevelopmentExpense",
                "unit": "usd",
                "value": 224519000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -273156000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -273156000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -273156000
            },
            {
                "label": "Cost of products sold",
                "concept": "CostOfGoodsAndServicesSold",
                "unit": "usd",
                "value": 109000
            },
            {
                "label": "Selling, general and administrative",
                "concept": "SellingGeneralAndAdministrativeExpense",
                "unit": "usd",
                "value": 91377000
            },
            {
                "label": "Loss from operations",
                "concept": "OperatingIncomeLoss",
                "unit": "usd",
                "value": -261519000
            },
            {
                "label": "Weighted-average shares used in computing net loss per share, basic and diluted",
                "concept": "WeightedAverageNumberOfShareOutstandingBasicAndDiluted",
                "unit": "shares",
                "value": 142713463
            },
            {
                "label": "Net loss per share, basic and diluted",
                "concept": "EarningsPerShareBasicAndDiluted",
                "unit": "usd/shares",
                "value": -1.82
            },
            {
                "label": "Net loss attributable to redeemable convertible noncontrolling interests and noncontrolling interests",
                "concept": "NetIncomeLossAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -13729000
            },
            {
                "label": "Interest income",
                "concept": "InvestmentIncomeInterest",
                "unit": "usd",
                "value": 717000
            },
            {
                "label": "Total operating costs and expenses",
                "concept": "CostsAndExpenses",
                "unit": "usd",
                "value": 316005000
            },
            {
                "label": "Comprehensive loss attributable to redeemable convertible noncontrolling interests and noncontrolling interests",
                "concept": "ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -13729000
            },
            {
                "label": "Comprehensive loss attributable to common stockholders of BridgeBio",
                "concept": "ComprehensiveIncomeNetOfTax",
                "unit": "usd",
                "value": -259583000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -273156000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -273156000
            },
            {
                "label": "Net loss",
                "concept": "ProfitLoss",
                "unit": "usd",
                "value": -273156000
            },
            {
                "label": "Unrealized gain (loss) on available-for-sale securities",
                "concept": "OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax",
                "unit": "usd",
                "value": -156000
            },
            {
                "label": "Comprehensive loss",
                "concept": "ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest",
                "unit": "usd",
                "value": -273312000
            }
        ]
    }
}